Skip to main content
OARK logo
OARK
(NYSEARCA)
YieldMax Innovation Option Income Strategy ETF
$29.40-- (--)
Loading... - Market loading

OARK ETF: YieldMax Innovation Option Income Strategy ETF - Price, Holdings & Analysis

YieldMax Innovation Option Income Strategy ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$29.79 - $30.07
52-Week High$47.00
52-Week Low$26.89
Open$30.07
Volume7.92K
Average Volume (3M)7.31K
Assets (AUM)31.33M
Expense Ratio1.00%
Total Holdings18
Inception DateNov 22, 2022
1 Day Change-0.38%
1 Month Change2.56%
6 Month Change-9.23%
YTD Change-18.42%
1 Year Change-29.87%
52-Week Change-29.46%
50-Day MA$29.56
200-Day MA$32.71
RSI52.73
Stochastic %K67.08
Stochastic %D59.98
Annual Dividend$16.53
Dividend Yield55.34%
Last Dividend Ex-DateSep 3, 2026
Dividend Growth YoY-27.99%

Frequently Asked Questions About YieldMax Innovation Option Income Strategy ETF

What is the current price of OARK?

The latest OARK price is $29.87. The 52-week range is $26.89–$47.00. OARK has returned -29.5% over the past 52 weeks.

What is the expense ratio for OARK?

OARK's annual expense ratio is 1.00%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.

Does OARK pay dividends?

Yes, OARK pays a 55.34% dividend yield. The last ex-dividend date was 2026-09-03. View full dividend history in the Dividends section.

What are the top holdings of OARK?

OARK's largest holdings are United States Treasury Bills 0% (31.4%), United States Treasury Bills 0% (30.8%), United States Treasury Bills 0% (27.2%) (combined weight: 89.4%). The fund holds 18 total positions. View the complete portfolio breakdown in the Holdings section.

How does OARK compare to similar ETFs?

Compare OARK (1.00% expense ratio, $31M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.